Somatic mutations reveal hyperactive Notch signaling in prurigo nodularis
Authors:
- Ahmad RajehARAhmad Rajeh
- Shahin ShahsavariSSShahin Shahsavari
- Hannah CornmanHCHannah Cornman
- Alexander KollhoffAKAlexander Kollhoff
- Anuj GuptaAGAnuj Gupta
- Mindy D SzetoMSMindy D Szeto
- Anusha KambalaAKAnusha Kambala
- Olusola O OladipoOOOlusola O Oladipo
- Varsha ParthasarathyVPVarsha Parthasarathy
- Junwen DengJDJunwen Deng
- Melika MaraniMMMelika Marani
- Shirin ShahsavariSSShirin Shahsavari
Open Access
- 26 February 2026
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 11 (8)
Abstract
Prurigo nodularis (PN) is a chronic inflammatory skin disease characterized by pruritic skin nodules of unknown etiology. Little is known about genetic changes in PN pathogenesis, particularly somatic events, which are often implicated in inflammatory conditions. We thus performed whole-exome sequencing on 54 lesional and nonlesional skin biopsies from 17 patients with PN and 10 patients with atopic dermatitis (AD) for comparison. Somatic mutational analysis revealed that PN lesional skin harbors recurrent somatic mutations in fibrotic, neurotropic, and cancer-associated genes that are absent in adjacent PN nonlesional skin. Nonsynonymous mutations were most frequently present in NOTCH1 and the Notch signaling pathway, a key regulator of cellular proliferation and tissue fibrosis. In contrast, NOTCH1 mutations were absent in AD. Somatic copy-number analysis, combined with expression data, identified recurrently deleted and downregulated genes in PN lesional skin, which are associated with axonal guidance and extension. Follow-up immunofluorescence validation demonstrated increased NOTCH1 expression in PN lesional skin fibroblasts and increased Notch signaling in PN lesional dermis. Finally, a multicenter analysis revealed increased risk of NOTCH1 -associated diseases in patients with PN. In characterizing the somatic landscape of PN, this study highlights the potential role of Notch pathway dysregulation in PN pathogenesis and fibrosis.Keywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K23AR077073)
- Skin of Color Society (n/a)
- Dermatology Foundation (n/a)
- Instituto Nacional de Cancerología (P30CA006973)
This publication has 98 references indexed in Scilit:
- Modulation of Neuroimmune and Epithelial Dysregulation in Patients With Moderate to Severe Prurigo Nodularis Treated With NemolizumabJAMA Dermatology, 2023
- Association between prurigo nodularis and malignancy in middle-aged adultsJournal of the American Academy of Dermatology, 2019
- Missense Variants in the Histone Acetyltransferase Complex Component Gene TRRAP Cause Autism and Syndromic Intellectual DisabilityThe American Journal of Human Genetics, 2019
- Regulation of periostin expression by Notch signaling in hepatocytes and liver cancer cell linesBiochemical and Biophysical Research Communications, 2018
- Ethnic differences and comorbidities of 909 prurigo nodularis patientsJournal of the American Academy of Dermatology, 2018
- Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trialJournal of the American Academy of Dermatology, 2018
- Oncogenic Signaling Pathways in The Cancer Genome AtlasCell, 2018
- Molecular mechanisms in atopic eczema: insights gained from genetic studiesThe Journal of Pathology, 2016
- Functional and Genetic Analysis of Epiplakin in Epithelial Cells2016
- Deciphering Signatures of Mutational Processes Operative in Human CancerCell Reports, 2013